This activity is supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.
On-demand CE Webinar
K. Melissa Smith, DNP, ANP-BC, CHFN
Instructor of Nursing
Vanderbilt University School of Nursing
Adult Nurse Practitioner
The Heart Center at Meharry
Nashville General Hospital
During this activity, expert faculty will outline the major underlying causes of hyponatremia in HF patients, the 2013 EPR guidelines and differential algorithms for diagnosis, the safety and efficacy of current treatment options, and the complexities of HF to take into consideration when individualizing treatment. The vital role of the nurse practitioner will also be discussed to demonstrate the benefits of different perspectives in the diagnosis and treatment of these patients. Finally, experts will provide clinicians with the ability to integrate diagnostic strategies into clinical practice and select treatment options for HF patients with hyponatremia in order to optimize patient outcomes.
At the completion of this activity, the participant will be able to:
Recognize hyponatremia high risk patients including those with HF
Articulate the role of the Nurse Practitioner in the identification, management of patients with hyponatremia
Select treatment options for hyponatremia in patients with HF based on the efficacy and safety of available therapies and individual patient profiles.
Explain how to manage patients with hypervolemic and euvolemic hyponatremia, inclusive of safe and effective use of indicated medical interventions
Describe how to implement strategies that may reduce hospitalization and readmission, such as adherence to therapy, appropriate
May 16, 2017
May 16, 2018
Length of Webinar:
This activity is jointly provided by Global Education Group and Physicians' Education Resource®, LLC.
How to Obtain Credit
To receive credit, participants must complete the online pretest, view the activity in its entirety, and complete the online post-test and activity evaluation form. After completing the online assessment tests, and completing the activity evaluation form, participants may request credit. All participants must request credit before May 16, 2018. CE credit will not be issued after this date.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and PER. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1.0 contact hour(s) which includes 1.0 hour(s) of pharmacology.
Activity ID #2291E.
This activity was planned in accordance with AANP CE Standards and Policies.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The following contributors have no relevant financial relationships with commercial interests to disclose.
K. Melissa Smith, DNP, ANP-BC, CHFN
Physicians’ Education Resource®, LLC
: Dave Heckard, Maryjo Dixon, RPh, Donna Fausak, and Nicole Grassano.
Global Education Group Planners/Mangers:
Kristen Delisi, NP, Lindsay Borvansky, Laura Gilsdorf and Andrea Funk.
Anonymous peer reviewers have been used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and ArcMesa do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Required: Windows 7, Vista, XP, 2003 Server or 2000
Required: Mac OS X 10.4.11 (Tiger) or newer
For questions about this Internet CE activity, please contact: firstname.lastname@example.org